ResMed Inc.
RMD
$201.88
-$0.58-0.29%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.54B | 5.40B | 5.26B | 5.15B | 5.02B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.54B | 5.40B | 5.26B | 5.15B | 5.02B |
| Cost of Revenue | 2.09B | 2.08B | 2.07B | 2.06B | 2.04B |
| Gross Profit | 3.44B | 3.32B | 3.19B | 3.09B | 2.98B |
| SG&A Expenses | 1.08B | 1.05B | 1.01B | 991.02M | 968.08M |
| Depreciation & Amortization | 79.74M | 78.98M | 78.09M | 77.39M | 75.34M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.61B | 3.55B | 3.49B | 3.46B | 3.41B |
| Operating Income | 1.92B | 1.85B | 1.76B | 1.69B | 1.61B |
| Income Before Tax | 1.90B | 1.82B | 1.74B | 1.68B | 1.58B |
| Income Tax Expenses | 383.74M | 332.81M | 302.96M | 276.84M | 263.99M |
| Earnings from Continuing Operations | 1.52K | 1.49K | 1.44K | 1.40K | 1.31K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.52B | 1.49B | 1.44B | 1.40B | 1.31B |
| EBIT | 1.92B | 1.85B | 1.76B | 1.69B | 1.61B |
| EBITDA | 2.12B | 2.02B | 1.94B | 1.86B | 1.76B |
| EPS Basic | 10.41 | 10.16 | 9.81 | 9.55 | 8.94 |
| Normalized Basic EPS | 8.37 | 7.94 | 7.57 | 7.20 | 6.81 |
| EPS Diluted | 10.37 | 10.11 | 9.77 | 9.51 | 8.91 |
| Normalized Diluted EPS | 8.34 | 7.91 | 7.54 | 7.17 | 6.78 |
| Average Basic Shares Outstanding | 583.84M | 585.22M | 586.18M | 586.86M | 587.31M |
| Average Diluted Shares Outstanding | 586.03M | 587.53M | 588.64M | 589.34M | 589.83M |
| Dividend Per Share | 2.33 | 2.26 | 2.19 | 2.12 | 2.07 |
| Payout Ratio | 22.39% | 22.25% | 22.31% | 22.19% | 23.14% |